Prognostic Impact of Chronic Vasodilator Therapy in Patients With Vasospastic Angina
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lim, Yongwhan | - |
dc.contributor.author | Kim, Min Chul | - |
dc.contributor.author | Ahn, Youngkeun | - |
dc.contributor.author | Cho, Kyung Hoon | - |
dc.contributor.author | Sim, Doo Sun | - |
dc.contributor.author | Hong, Young Joon | - |
dc.contributor.author | Kim, Ju Han | - |
dc.contributor.author | Jeong, Myung Ho | - |
dc.contributor.author | Baek, Sang Hong | - |
dc.contributor.author | Her, Sung-Ho | - |
dc.contributor.author | Lee, Kwan Yong | - |
dc.contributor.author | Han, Seung Hwan | - |
dc.contributor.author | Rha, Seung-Woon | - |
dc.contributor.author | Choi, Dong-Ju | - |
dc.contributor.author | Gwon, Hyeon-Cheol | - |
dc.contributor.author | Kwon, Hyuck Moon | - |
dc.contributor.author | Yang, Tae-Hyun | - |
dc.contributor.author | Park, Keun-Ho | - |
dc.contributor.author | Jo, Sang-Ho | - |
dc.date.accessioned | 2022-04-22T03:40:23Z | - |
dc.date.available | 2022-04-22T03:40:23Z | - |
dc.date.created | 2022-04-22 | - |
dc.date.issued | 2022-04-05 | - |
dc.identifier.issn | 2047-9980 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/84081 | - |
dc.description.abstract | Background Chronic vasodilator therapy with long-acting nitrate is frequently used to treat vasospastic angina. However, the clinical benefits of this approach are controversial. We investigated the prognostic impact of vasodilator therapy in patients with vasospastic angina from the multicenter, prospective VA-KOREA (Vasospastic Angina in KOREA) registry. Methods and Results We analyzed data from 1895 patients with positive intracoronary ergonovine provocation test results. The patients were divided into 4 groups: no vasodilator (n=359), nonnitrate vasodilator (n=1187), conventional nitrate (n=209), and a combination of conventional nitrate and other vasodilators (n=140). The primary end point was a composite of cardiac death, acute coronary syndrome, and new-onset arrhythmia at 2 years. Secondary end points were the individual components of the primary end point, all-cause death, and rehospitalization due to recurrent angina. The groups did not differ in terms of the risk of the primary end point. However, the acute coronary syndrome risk was significantly higher in the conventional nitrate (hazard ratio [HR], 2.49; 95% CI, 1.01-6.14; P=0.047) and combination groups (HR, 3.34; 95% CI, 1.15-9.75, P=0.027) compared with the no-vasodilator group, as assessed using the inverse probability of treatment weights. Subgroup analyses revealed prominent adverse effects of nitrate in patients with an intermediate positive ergonovine provocation test result and in those with low Japanese Coronary Spasm Association scores. Conclusions Long-acting nitrate-based chronic vasodilator therapy was associated with an increased 2-year risk of acute coronary syndrome in patients with vasospastic angina, especially in low-risk patients. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | WILEY | - |
dc.relation.isPartOf | JOURNAL OF THE AMERICAN HEART ASSOCIATION | - |
dc.title | Prognostic Impact of Chronic Vasodilator Therapy in Patients With Vasospastic Angina | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000778262600057 | - |
dc.identifier.doi | 10.1161/JAHA.121.023776 | - |
dc.identifier.bibliographicCitation | JOURNAL OF THE AMERICAN HEART ASSOCIATION, v.11, no.7, pp.e023776 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.scopusid | 2-s2.0-85128245444 | - |
dc.citation.startPage | e023776 | - |
dc.citation.title | JOURNAL OF THE AMERICAN HEART ASSOCIATION | - |
dc.citation.volume | 11 | - |
dc.citation.number | 7 | - |
dc.contributor.affiliatedAuthor | Han, Seung Hwan | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | nitrates | - |
dc.subject.keywordAuthor | outcomes | - |
dc.subject.keywordAuthor | variant angina pectoris | - |
dc.subject.keywordAuthor | vasodilator agents | - |
dc.subject.keywordPlus | LONG-TERM PROGNOSIS | - |
dc.subject.keywordPlus | VARIANT ANGINA | - |
dc.subject.keywordPlus | MULTICENTER REGISTRY | - |
dc.subject.keywordPlus | MYOCARDIAL-ISCHEMIA | - |
dc.subject.keywordPlus | SPASM | - |
dc.subject.keywordPlus | NITROGLYCERIN | - |
dc.subject.keywordPlus | ARTERIES | - |
dc.relation.journalResearchArea | Cardiovascular System & Cardiology | - |
dc.relation.journalWebOfScienceCategory | Cardiac & Cardiovascular Systems | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.